Controversial Peptide Use Grows Despite Safety Concerns
A peptide promoted for healing is gaining popularity without FDA approval, raising safety and efficacy questions, reports Reuters.
Read the story at Yahoo News (opens in a new tab)
Originally reported by Yahoo News. Senior Wellness summarises the reporting; we do not publish the original article.
According to Reuters, the use of an experimental peptide known as BPC-157 is on the rise in the U.S., despite lacking approval from the Food and Drug Administration (FDA). This peptide is marketed for benefits like pain relief and improved healing, but there's little solid evidence supporting these claims.
U.S. Health Secretary Robert F. Kennedy Jr. has backed the peptide, and a recent analysis shows its growing usage among consumers seeking alternative treatments. The FDA has yet to decide on allowing its compounding, keeping it in a legal gray area.
Research indicates the typical user profile has shifted over time, with more males using it and the average age dropping. Concerns arise as reports of adverse effects, such as neuropsychiatric and gastrointestinal issues, have surfaced.
The analysis emphasizes the need for more rigorous studies to assess the safety and effectiveness of BPC-157. Seniors considering this peptide should consult with their healthcare provider to better understand the potential risks and benefits.
Related Conditions
Bowel Issues
Bowel issues are common among seniors, often leading to discomfort, inconvenience, and reduced quality of life. These issues can range from constipation and diarrhea to more serious conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).
Complex Regional Pain Syndrome (CRPS)
Complex Regional Pain Syndrome (CRPS) is a chronic pain condition, often occurring after an injury or surgery, primarily affecting a limb. This syndrome can cause severe pain, swelling, and noticeable changes in skin appearance. Seniors may face additional challenges managing CRPS due to other health conditions.